Conclusions Trop-2 protein overexpression is significantly associated with higher tumor grade and serves as an independent prognostic factor for DFS in endometrioid endometrial cancer.

For patients with advanced or recurrent endometrial cancer ... effects of any grade. Notably, grade 3 (severe) to 4 (life-threatening) treatment-related side effects occurring in 76% and 66% of ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...

This trial included 36 women with ovarian cancer and six with endometrial cancer ... fatigue and vomiting were primarily grade 1/2 [7] Naumann et al. (2009) No grade 4 toxicities were elicited ...

GSK plc GSK announced that the European Commission has granted approval for the expanded use of Jemperli (dostarlimab) plus ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

Interim data was announced last November, where 6 out of 11 patients with platinum-resistant ovarian cancer had tumor shrinkage with ... can be amplified. High-grade thrombocytopenia (reduction ...

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target lowered by HC Wainwright from $20.00 to $10.00 in a research report released on Wednesday,Benzinga reports. The firm currently ...

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target decreased by UBS Group from $5.00 to $2.20 in a research report released on Tuesday,Benzinga reports. UBS Group currently has ...

Learn more about whether AbbVie Inc. or Genmab A/S is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.